New units of the 2027 GMC Terrain are rolling off the line now, introducing a few interesting updates over the preceding 2026 Terrain, such as new technology features and higher towing capacity for ...

Initial phase 1b/2 study results of purinostat mesylate (PM) in combination with pomalidomide (POM) and low dexamethasone (DEX) in patients with RRMM. This is an ASCO Meeting Abstract from the 2026 ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Cory Fernandez Commerce Editor Summer is almost here and ...

The share of people working multiple jobs has been on the rise in recent years. In a 2025 survey from Fiverr, 64% of Gen Z respondents in the U.S. said having multiple ways to earn money is essential ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

Democrats believe they now have “multiple paths” to flipping the Senate this year, touting strong recruits in some deep red states and a message focused on costs and health care. And, for the first ...